C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2004
12/23/2004	US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis
12/23/2004	US20040259904 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259887 Cannabinoid receptor ligands and uses thereof
12/23/2004	US20040259884 Antiproliferative agents; antitumor agents; using 1-(4,5-bis(4-chlorophenyl)-2-(2,4-dimethoxyphenyl)-4,5-imidazol-1-yl)-2-methylpropan-1-one
12/23/2004	US20040259882 E.g., 2-tert-butyl-4-(4-(3-(4-methyl-5-methyl-4H-(1,2,4)-triazol-3-ylsulfanyl) -propyl)piperazin-1-yl)-6-tert-butyl-pyri midine; high affinities; central nervous system disorders schizophrenia; antidepressants; Parkinson's and Alzheimer's
12/23/2004	US20040259881 Nitrogenous heterocyclic compounds
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259876 Bicyclic compound, production and use thereof
12/23/2004	US20040259870 Antidiabetic agents; obesity; controlling appetite
12/23/2004	US20040259867 Antiproliferative agents; antitumor agents
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
12/23/2004	US20040259843 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
12/23/2004	US20040259826 Mitotic kinesin inhibitors
12/23/2004	US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
12/23/2004	US20040259031 Specific dye compound, optical information recording medium comprising specific dye, and information recording method using this optical information recording medium
12/23/2004	US20040255397 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers
12/23/2004	CA2756058A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2529090A1 2-aminopyrimidine derivatives as raf kinase inhibitors
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	CA2528888A1 N-heterocyclylphenyl-substituted cyclic ketoenols
12/23/2004	CA2528652A1 Nk1 antagonist
12/23/2004	CA2528321A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2527035A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2526872A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2526770A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2004	EP1489155A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/22/2004	EP1489080A1 Process for producing cilostazol
12/22/2004	EP1489061A1 Process for producing cyclic compound
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1488789A1 Eye drops containing tetrazole derivative
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487824A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487819A2 Azepane derivatives and their use as atk1 inhibitors
12/22/2004	EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487803A1 Indazoles substituted with an anti-cancerous activity
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487798A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
12/22/2004	EP1487792A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
12/22/2004	EP1487474A2 Intranasal administration of mc4-r agonists
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	EP1487436A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers
12/22/2004	EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists
12/22/2004	EP1436266A4 Methods and compositions of novel triazine compounds
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	CN1556839A Cationic reactive dyes
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1181069C Novel inhibitors of farnesyl-protein transferase
12/22/2004	CN1181057C Novel 5-pyrimidine carboxamide derivatives and pharmaceutical compositions containing said derivatives
12/21/2004	US6833387 Chemical compounds
12/21/2004	US6833384 Deacetylase inhibitors
12/21/2004	US6833381 TNF-α inhibitors
12/21/2004	US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/21/2004	US6833364 Inhibiting degradation of cyclic guanosine monophosphate; cardiovascular disorders; such as 3-(4-amino-5-cyclopropyl-pyrimidin-2-yl)-1-(2-fluorobenzyl)1H-pyrazolo-(3,4 -b)-pyridine
12/16/2004	WO2004108711A1 Pyrazinil quinazoline derivatives for use in the treatment of tumours
12/16/2004	WO2004108708A1 3-substituted indoles and derivatives thereof as therapeutic agents
12/16/2004	WO2004108707A1 Pyridazinil quinazoline derivatives for use in the treatment of tumours
12/16/2004	WO2004108706A1 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
12/16/2004	WO2004108702A1 Indole derivatives with apoptosis-inducing effect
12/16/2004	WO2004108692A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108687A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
12/16/2004	WO2004108684A1 Novel azole derivative having antifungal activity
12/16/2004	WO2004108683A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
12/16/2004	WO2004108681A1 Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
12/16/2004	WO2004108672A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	WO2004108669A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004087677A3 Pyrimidin-4-one derivatives and their use as p38 kinase modulators
12/16/2004	WO2004065383A3 Novel synthesis of irbesartan
12/16/2004	WO2003105538A8 Electroluminescent device
12/16/2004	WO2002076177A3 Design and synthesis of optimized ligands for ppar
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254215 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
12/16/2004	US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004	US20040254188 such as N-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-N'-5-isoquinolinylurea; for treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity
12/16/2004	US20040254179 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/16/2004	US20040254164 3-(imidazolyl)-2-alkoxypropanoic acids
12/16/2004	US20040254159 Antiproliferative agents
12/16/2004	CA2528044A1 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
12/16/2004	CA2528006A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/16/2004	CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	CA2527779A1 3-substituted indoles and derivatives thereof as therapeutic agents
12/15/2004	EP1486550A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485379A1 Beta 3-adrenergic receptor agonists
12/15/2004	EP1485378A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485376A1 Compositions useful as inhibitors of protein kinases
12/15/2004	EP1485375A1 Pyrimidine compounds

1 ... 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 ... 626